These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 20931348)
1. Are the current IHS guidelines for migraine drug trials being followed? Hougaard A; Tfelt-Hansen P J Headache Pain; 2010 Dec; 11(6):457-68. PubMed ID: 20931348 [TBL] [Abstract][Full Text] [Related]
2. Adherence to the 2008 IHS guidelines for controlled trials of drugs for the preventive treatment of chronic migraine in adults. Deen M; Martinelli D; Pijpers J; Diener HC; Silberstein S; Ferrari MD; Ashina M; Tassorelli C; Yuan H Cephalalgia; 2019 Jul; 39(8):1058-1066. PubMed ID: 31042062 [TBL] [Abstract][Full Text] [Related]
3. Have the IHS Alpuente A; Tassorelli C; Diener HC; Silberstein SD; Pozo-Rosich P Cephalalgia; 2020 Jul; 40(8):778-787. PubMed ID: 32056459 [TBL] [Abstract][Full Text] [Related]
4. Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Silberstein S; Tfelt-Hansen P; Dodick DW; Limmroth V; Lipton RB; Pascual J; Wang SJ; Cephalalgia; 2008 May; 28(5):484-95. PubMed ID: 18294250 [TBL] [Abstract][Full Text] [Related]
5. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
6. General lack of use of placebo in prophylactic, randomised, controlled trials in adult migraine. A systematic review. Hougaard A; Tfelt-Hansen P Cephalalgia; 2016 Sep; 36(10):960-9. PubMed ID: 26553731 [TBL] [Abstract][Full Text] [Related]
7. Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Oskoui M; Pringsheim T; Billinghurst L; Potrebic S; Gersz EM; Gloss D; Holler-Managan Y; Leininger E; Licking N; Mack K; Powers SW; Sowell M; Victorio MC; Yonker M; Zanitsch H; Hershey AD Neurology; 2019 Sep; 93(11):500-509. PubMed ID: 31413170 [TBL] [Abstract][Full Text] [Related]
8. Evaluating the reporting of adverse events in controlled clinical trials conducted in 2010-2015 on migraine drug treatments. Tfelt-Hansen P; Lindqvist JK; Do TP Cephalalgia; 2018 Oct; 38(12):1885-1895. PubMed ID: 29448820 [TBL] [Abstract][Full Text] [Related]
9. Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators. Tfelt-Hansen P; Pascual J; Ramadan N; Dahlöf C; D'Amico D; Diener HC; Hansen JM; Lanteri-Minet M; Loder E; McCrory D; Plancade S; Schwedt T; Cephalalgia; 2012 Jan; 32(1):6-38. PubMed ID: 22384463 [No Abstract] [Full Text] [Related]
10. International Headache Society global practice recommendations for the acute pharmacological treatment of migraine. Puledda F; Sacco S; Diener HC; Ashina M; Al-Khazali HM; Ashina S; Burstein R; Liebler E; Cipriani A; Chu MK; Cocores A; Dodd-Glover F; Ekizoğlu E; Garcia-Azorin D; Göbel C; Goicochea MT; Hassan A; Hirata K; Hoffmann J; Jenkins B; Kamm K; Lee MJ; Ling YH; Lisicki M; Martinelli D; Monteith TS; Ornello R; Ozge A; Peres M; Pozo-Rosich P; Romanenko V; Schwedt TJ; Souza MNP; Takizawa T; Terwindt GM; Thuraiaiyah J; Togha M; Vandenbussche N; Wang SJ; Yu S; Tassorelli C Cephalalgia; 2024 Aug; 44(8):3331024241252666. PubMed ID: 39133176 [TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Cady R; Schreiber C Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501 [TBL] [Abstract][Full Text] [Related]
13. Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Oskoui M; Pringsheim T; Holler-Managan Y; Potrebic S; Billinghurst L; Gloss D; Hershey AD; Licking N; Sowell M; Victorio MC; Gersz EM; Leininger E; Zanitsch H; Yonker M; Mack K Neurology; 2019 Sep; 93(11):487-499. PubMed ID: 31413171 [TBL] [Abstract][Full Text] [Related]
14. Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition. Abu-Arafeh I; Hershey AD; Diener HC; Tassorelli C; Cephalalgia; 2019 Jun; 39(7):803-816. PubMed ID: 30947525 [TBL] [Abstract][Full Text] [Related]
15. Canadian Headache Society systematic review and recommendations on the treatment of migraine pain in emergency settings. Orr SL; Aubé M; Becker WJ; Davenport WJ; Dilli E; Dodick D; Giammarco R; Gladstone J; Leroux E; Pim H; Dickinson G; Christie SN Cephalalgia; 2015 Mar; 35(3):271-84. PubMed ID: 24875925 [TBL] [Abstract][Full Text] [Related]
16. American Headache Society members' assessment of headache diagnostic criteria. Nash JM; Lipchik GL; Holroyd KA; McCool H; Stensland M; Headache; 2003 Jan; 43(1):2-13. PubMed ID: 12864752 [TBL] [Abstract][Full Text] [Related]
17. Eletriptan for acute migraine. Smith LA; Oldman AD; McQuay HJ; Moore RA Cochrane Database Syst Rev; 2001; (3):CD003224. PubMed ID: 11687056 [TBL] [Abstract][Full Text] [Related]
18. Do ED patients with migraine headaches meet internationally accepted criteria? Fiesseler FW; Kec R; Mandell M; Eskin B; Anannab M; Riggs RL; Richman PB Am J Emerg Med; 2002 Nov; 20(7):618-23. PubMed ID: 12442241 [TBL] [Abstract][Full Text] [Related]
19. Drugs for preventing migraine headaches in children. Victor S; Ryan SW Cochrane Database Syst Rev; 2003; (4):CD002761. PubMed ID: 14583952 [TBL] [Abstract][Full Text] [Related]